EdgeMarket › What Bronte Capital Management Pty Ltd. reported owning

What Bronte Capital Management Pty Ltd. reported owning

As filed on Form 13F for the quarter ending 2026-03-31, up to 45 days after that date. Long-only US-listed equity — shorts, bonds, cash and non-US listings are not on the form, so this is one leg of the book, not the book.

Reported value

1.0B

Positions

54

Quarter

2026-03-31

Shown below

50
largest by value
holdingvalue% of booksharesprice1y
REGN
REGENERON PHARMACEUTICALS, INC.
133.5M13.2%172.8K834.04+41.1%
GOOGL
Alphabet Inc.
109.7M10.9%381.5K344.82+73.0%
IBKR
Interactive Brokers Group, Inc.
86.0M8.5%1.3M93.87+50.3%
unmapped CUSIP 08467070274.3M7.4%155.1K
unmapped CUSIP 83601L10572.3M7.2%239.4K
AMZN
AMAZON COM INC
59.5M5.9%285.7K258.63+15.6%
PM
Philip Morris International Inc.
56.4M5.6%341.1K188.23+8.9%
CTVA
Corteva, Inc.
42.1M4.2%502.8K81.79+12.1%
COF
CAPITAL ONE FINANCIAL CORP
34.2M3.4%187.4K217.91+1.5%
FCNCA
FIRST CITIZENS BANCSHARES INC /DE/
31.1M3.1%16.5K2,183.54+13.1%
unmapped CUSIP M8216R11019.1M1.9%208.1K
DIS
Walt Disney Co
17.9M1.8%185.7K107.78-7.9%
TBBB
BBB FOODS INC
17.2M1.7%487.6K50.66+95.8%
NKTR
NEKTAR THERAPEUTICS
14.3M1.4%198.3K74.02+174.7%
HLF
HERBALIFE LTD.
13.8M1.4%939.9K12.65+34.4%
GHC
Graham Holdings Co
13.5M1.3%12.8K1,166.93+9.3%
unmapped CUSIP 11563790013.1M1.3%493.9K
ALNY
ALNYLAM PHARMACEUTICALS, INC.
12.3M1.2%37.2K236.22-48.5%
unmapped CUSIP 83601L10312.1M1.2%843.7K
IWO
iShares Russell 2000 Growth Fund
11.8M1.2%37.5K387.37+31.0%
IBB
iShares Biotechnology ETF
11.7M1.2%69.3K213.56+54.3%
SQM
CHEMICAL & MINING CO OF CHILE INC
9.9M1.0%122.4K81.96+84.8%
AUR
Aurora Innovation, Inc.
9.6M0.9%2.3M6.24+8.1%
NEM
NEWMONT Corp /DE/
8.2M0.8%75.4K131.58+90.7%
PINS
PINTEREST, INC.
7.9M0.8%430.9K23.40-34.0%
GLBE
Global-E Online Ltd.
6.6M0.7%213.1K40.55+27.4%
B
BARRICK MINING CORP
6.5M0.6%158.7K47.60+91.6%
RAMP
LiveRamp Holdings, Inc.
5.9M0.6%223.2K37.58+41.0%
PCTY
Paylocity Holding Corp
4.0M0.4%36.6K153.34-15.4%
TPB
Turning Point Brands, Inc.
3.7M0.4%42.9K83.41-14.4%
MDLZ
Mondelez International, Inc.
3.2M0.3%56.0K64.45+2.0%
unmapped CUSIP 83601L1043.2M0.3%26.6K
SBH
Sally Beauty Holdings, Inc.
3.1M0.3%220.7K16.57+26.4%
BBWI
Bath & Body Works, Inc.
2.9M0.3%155.5K19.45-34.3%
unmapped CUSIP 1156371002.7M0.3%100.4K
JRVR
James River Group Holdings, Inc.
2.1M0.2%339.0K4.05-31.2%
RSKD
RISKIFIED LTD.
1.9M0.2%488.5K5.90+41.8%
NICE
NICE Ltd.
1.9M0.2%17.1K100.24-27.3%
OLED
UNIVERSAL DISPLAY CORP \PA\
1.0M0.1%11.1K85.84-38.8%
VRSK
Verisk Analytics, Inc.
550.7K0.1%2.9K187.50-30.8%
ENVX
Enovix Corp
59.8K0.0%11.6K3.38-66.5%
ALEC
Alector, Inc.
41.5K0.0%19.3K2.36+7.3%
CHRS
Coherus Oncology, Inc.
32.6K0.0%19.3K1.42+32.7%
CRBU
Caribou Biosciences, Inc.
29.7K0.0%15.6K1.66-7.8%
FATE
FATE THERAPEUTICS INC
27.4K0.0%22.9K2.33+106.2%
CCCC
C4 Therapeutics, Inc.
26.4K0.0%10.0K4.00+53.8%
PLRX
PLIANT THERAPEUTICS, INC.
23.5K0.0%18.6K1.16-19.2%
IVVD
Invivyd, Inc.
14.3K0.0%11.0K1.00+57.2%
MIST
Milestone Pharmaceuticals Inc.
12.4K0.0%10.4K1.05-35.7%
RANI
Rani Therapeutics Holdings, Inc.
10.9K0.0%14.9K0.88+66.2%

A position that grew quarter on quarter may simply reflect a higher price: if the stock rose 40% and the manager did nothing, the reported value rose 40%. Reading that as accumulation is reading the price back to yourself. More on that →

The whole archive is one click away.

Screener, filings, insider flow, backtests and the AI — open without an account.

Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →